Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 639	$ 170
Trade accounts and other receivables (net of allowance of $6 at March 31, 2017 and $6 at December 31, 2016)	867	938
Inventories	148	138
Assets held for sale (Note 1)	1,023	24
Other current assets and deferred charges	168	192
Total current assets	2,845	1,462
Investments	6,738	6,701
Property, plant, and equipment, at cost	38,342	38,912
Accumulated depreciation and amortization	(10,580)	(10,484)
Property, plant, and equipment – net	27,762	28,428
Intangible assets – net of accumulated amortization	9,570	9,663
Regulatory assets, deferred charges, and other	597	581
Total assets	47,512	46,835
Current liabilities:
Accounts payable	680	623
Liabilities held for sale (Note 1)	43	0
Accrued liabilities	1,322	1,448
Commercial paper	0	93
Long-term debt due within one year	0	785
Total current liabilities	2,045	2,949
Long-term debt	21,825	22,624
Deferred income tax liabilities	5,133	4,238
Regulatory liabilities, deferred income, and other	3,100	2,978
Contingent liabilities (Note 11)
Stockholders’ equity:
Common stock (960 million shares authorized at $1 par value; 861 million shares issued at March 31, 2017 and 785 million shares issued at December 31, 2016)	861	785
Capital in excess of par value	18,445	14,887
Retained deficit	(9,487)	(9,649)
Accumulated other comprehensive income (loss)	(334)	(339)
Treasury stock, at cost (35 million shares of common stock)	(1,041)	(1,041)
Total stockholders’ equity	8,444	4,643
Noncontrolling interests in consolidated subsidiaries	6,965	9,403
Total equity	15,409	14,046
Total liabilities and equity	$ 47,512	$ 46,835